Given that T2DM is associated with an impaired ability to use insulin, metformin was determined to be appropriate for use in this study to compare the effects of curing induced T2DM in mice, rather than insulin secretagogues and other types of medication. This evidence concerns the gene INS and type 2 diabetes mellitus.